Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
14.36
-0.78 (-5.15%)
Sep 23, 2026, 1:29 PM EDT - Market open
Alpha Tau Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Alpha Tau Medical stock has a consensus rating of "Buy" and an average price target of $17.8. The average 1-year stock price forecast is 23.96% higher than the current stock price, while the lowest is $8.00 (-44.29%) and the highest is $30 (+108.91%).
Price Target: $17.8 (+23.96%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alpha Tau Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $17 → $30 | Buy | Maintains | $17 → $30 | +108.91% | Sep 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $16 | Buy | Reiterates | $16 | +11.42% | Sep 1, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $8 | Hold | Reiterates | $8 | -44.29% | Aug 11, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Reiterates $14 | Buy | Reiterates | $14 | -2.51% | May 12, 2026 |
Financial Forecast
Revenue This Year
944.33K
Revenue Next Year
12.61M
from 944.33K
Increased by 1,235.59%
EPS This Year
-0.96
from -0.53
EPS Next Year
-0.53
from -0.96
EPS and Forward PE are based on non-GAAP adjusted numbers.